Skip to content

Clinical trials

Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 3 Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20023
20033
20042
20051
20064
20073
20081
20094
20104
20113
20127
20131
20147
20154
20162
20171
20183
20192
20212
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated13
Unknown status9
Active, not recruiting3
Recruiting2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals17
Medical College of Wisconsin3
Ariad Pharmaceuticals2
Fred Hutchinson Cancer Center2
Il-Yang Pharm. Co., Ltd.2
Novartis2
Pfizer2
Poitiers University Hospital2
St. Jude Children's Research Hospital2
University of Jena2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive71
Leukemia21
Leukemia, Myeloid, Chronic-Phase15
Myelodysplastic Syndromes13
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Leukemia, Myeloid, Acute11
Myeloproliferative Disorders9
Leukemia, Myeloid7
Lymphoma7
Bone Marrow Diseases6

Trials

Showing 26 to 50 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.